Dashboard
Manage Tickers

VERA Vera Therapeutics, Inc.

Nasdaq veratx.com


$ 29.21 $ 2.00 (7.19 %)    

Tuesday, 11-Nov-2025 19:43:24 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.57 $ 0.90 (0.15 %)
DIA $ 479.63 $ 5.34 (1.13 %)
SPY $ 683.36 $ 2.90 (0.43 %)
TLT $ 89.88 $ 0.01 (0.01 %)
GLD $ 380.70 $ -0.09 (-0.02 %)
$ 29.71
$ 27.73
$ 29.20 x 7
$ 29.93 x 105
$ 27.37 - $ 30.17
$ 18.53 - $ 51.61
1,722,910
na
1.9B
$ 0.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-28-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-27-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-28-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-25-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 06-24-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-vera-therapeutics-raises-price-target-to-90
HC Wainwright & Co. Maintains Buy on Vera ...
11/10/2025 11:57:42

HC Wainwright & Co. analyst Arthur He maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target f...

reported-friday-vera-therapeutics-submits-bla-to-fda-for-atacicept-after-origin-phase-3-interim-analysis-demonstrates-42-proteinuria-reduction-vs-placebo
Reported Friday, Vera Therapeutics Submits...
11/10/2025 09:40:43

Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint ...

jp-morgan-maintains-overweight-on-vera-therapeutics-lowers-price-target-to-52
JP Morgan Maintains Overweight on Vera The...
11/07/2025 20:31:55

JP Morgan analyst Anupam Rama maintains Vera Therapeutics (NASDAQ:VERA) with a Overweight and lowers the price target from $...

vera-therapeutics-data-from-origin-phase-3-study-of-atacicept-in-iga-nephropathy-demonstrated-46-reduction-from-baseline-in-proteinuria-meets-secondary-endpoints
Vera Therapeutics Data From ORIGIN Phase 3...
11/06/2025 14:53:25

Vera Therapeutics, Inc. (NASDAQ:VERA) today announced data from the ORIGIN Phase 3 trial of atacicept in IgA nephropathy (IgAN)...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/05/2025 17:35:20

vera-therapeutics-q3-eps-126-misses-116-estimate
Vera Therapeutics Q3 EPS $(1.26) Misses $(...
11/05/2025 12:30:34

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(1.26) per share which missed the analyst consensus estimate of $...

reported-earlier-vera-therapeutics-to-present-phase-3-atacicept-data-for-igan-in-featured-late-breaking-session-at-asn-kidney-week-2025
Reported Earlier: Vera Therapeutics To Pre...
10/17/2025 15:31:07

Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing tr...

vera-therapeutics-lead-kidney-drug-poised-for-2026-launch-in-multi-billion-dollar-market
Vera Therapeutics' Lead Kidney Drug Poised...
10/16/2025 18:17:37

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.

b-of-a-securities-initiates-coverage-on-vera-therapeutics-with-buy-rating-announces-price-target-of-48
B of A Securities Initiates Coverage On Ve...
10/16/2025 11:47:33

B of A Securities analyst Dina Ramadane initiates coverage on Vera Therapeutics (NASDAQ:VERA) with a Buy rating and announce...

6-stocks-goldman-sachs-says-are-poised-for-potential-acquisition-in-next-12-months--including-a-huge-200-winner
6 Stocks Goldman Sachs Says Are Poised For...
09/30/2025 13:11:43

Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year.

jp-morgan-maintains-overweight-on-vera-therapeutics-lowers-price-target-to-53
JP Morgan Maintains Overweight on Vera The...
08/07/2025 21:24:31

JP Morgan analyst Anupam Rama maintains Vera Therapeutics (NASDAQ:VERA) with a Overweight and lowers the price target from $...

vera-therapeutics-files-for-offering-of-up-to-200m-class-a-common-stock
Vera Therapeutics Files For Offering Of Up...
08/05/2025 21:00:17

- SEC Filing

vera-therapeutics-q2-2025-eps-120-misses-083-estimate-vera-reported-5568m-in-cash-cash-equivalents-and-marketable-securities
Vera Therapeutics Q2 2025 EPS $(1.20) Miss...
08/05/2025 11:13:49

Vera expects cash position to be sufficient to fund operations through potential approval and us commercial launch of Atacicept...

this-avalonbay-communities-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-monday
This AvalonBay Communities Analyst Is No L...
08/04/2025 11:47:31

wolfe-research-downgrades-vera-therapeutics-to-peer-perform
Wolfe Research Downgrades Vera Therapeutic...
08/04/2025 11:25:03

Wolfe Research analyst Andy Chen downgrades Vera Therapeutics (NASDAQ:VERA) from Outperform to Peer Perform.

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
07/18/2025 12:07:40

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
06/12/2025 17:35:23

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
06/06/2025 17:06:47

crude-oil-gains-2-abm-industries-shares-plunge-after-q2-results
Crude Oil Gains 2%; ABM Industries Shares ...
06/06/2025 16:17:36

dow-jumps-over-500-points-nonfarm-payrolls-top-estimates
Dow Jumps Over 500 Points; Nonfarm Payroll...
06/06/2025 13:54:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION